Clinton, MA, United States of America

Melissa Maxwell

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Phio Pharmaceuticals Corp.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melissa Maxwell. Retrieved from https://idiyas.com/inventor/melissa-maxwell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Melissa Maxwell: Innovator in Nucleic Acid Delivery

Introduction

Melissa Maxwell is a prominent inventor based in Clinton, MA (US). She has made significant contributions to the field of biotechnology, particularly in the delivery of nucleic acid compounds. Her innovative work has led to the development of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Melissa holds a patent titled "Topical Delivery of Nucleic Acid Compounds." This patent represents her commitment to improving therapeutic methods and enhancing the efficacy of nucleic acid treatments. With 1 patent to her name, she is making strides in a critical area of research.

Career Highlights

Melissa is currently employed at Phio Pharmaceuticals Corp., where she continues to work on groundbreaking projects. Her role at the company allows her to collaborate with other talented professionals in the field, furthering her impact on biotechnology.

Collaborations

One of her notable collaborators is Richard J. Looby. Together, they contribute to the innovative environment at Phio Pharmaceuticals Corp., working towards advancements in their field.

Conclusion

Melissa Maxwell is a dedicated inventor whose work in nucleic acid delivery is paving the way for future innovations in biotechnology. Her contributions are essential to the ongoing development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…